Patient Guide: Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 189 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05769777
Status: 🟢 Enrolling Now
Condition: Dermatitis, Atopic, Dermatitis
Phase: PHASE2

Where You Can Participate

This study is available at 189 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Litchfield Park, Arizona
  • • Phoenix, Arizona
  • • And 186 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis - Join Clinical Trial NCTNCT05769777

How to Join This Clinical Trial - NCTNCT05769777

Learn how to participate in this PHASE2 trial studying an investigational therapy for Dermatitis, Atopic, Dermatitis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Dermatitis, Atopic, Dermatitis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Dermatitis, Atopic, Dermatitis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05769777 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 189 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: RECRUITING

Clinical Research Site

Litchfield Park, Arizona 85340 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85006 - United States

Status: RECRUITING

Clinical Research Site

Bryant, Arkansas 72022 - United States

Status: RECRUITING

Clinical Research Site

Newport Beach, California 92660 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: RECRUITING

Clinical Research Site

Centennial, Colorado 80112 - United States

Status: RECRUITING

Clinical Research Site

Cape Coral, Florida 33991 - United States

Status: RECRUITING

Clinical Research Site

Coral Springs, Florida 33071 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33143 - United States

Status: RECRUITING

And 179 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Dermatitis, Atopic, Dermatitis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships